Thomas Brimert, PhD

Received a PhD in organic chemistry from the Royal Institute of Technology in Stockholm. During his 11 years at AstraZeneca R&D Lund, he gained considerable medicinal chemistry experience. He has contributed to successfully delivered clinical candidates in kinase, protease and receptor projects within the respiratory & inflammation therapy area.

During his post-doc with Prof. Jan Becher at the University of Odense in Denmark, he developed new synthetic methods to supramolecular building blocks. Thomas is co-author of 8 scientific publications and 8 patents.